InnoMedCatalyst Investors eBook highlights Europe’s next generation of digital and precision health innovators
The European InnoMedCatalyst (IMC) initiative has officially launched its Investors eBook as part of Round #2 of the InnoMedCatalyst Accelerator Program, showcasing 27 selected MedTech and HealthTech startups and spinoffs from across Europe.
The publication highlights innovative companies developing solutions in digital and precision healthcare, with a focus on the principles of 5P medicine: Preventive, Predictive, Personalized, Participatory and Precision healthcare. The featured startups were selected from a pool of more than 60 applicants to participate in the accelerator program.
As a partner within the InnoMedCatalyst initiative, Biovia has actively contributed to the program and the broader health innovation ecosystem that supports collaboration between startups, investors and healthcare stakeholders across Europe. The accelerator is designed to help innovative ventures move from validation to investment readiness and international growth through mentorship, coaching and direct investor engagement.
The newly launched Investors eBook aims to strengthen the visibility of participating companies while creating new opportunities for collaboration and investment at European level. According to program partners, stronger international investor networks and more diverse investment portfolios can ultimately benefit the wider regional innovation ecosystem as well.
The accelerator program also benefits from the expertise of experienced mentors and coaches, including Biovia partner Henk Joos, who supports the initiative and contributes to investor relations and startup selection activities within the program.
You can explore the eBook here.